Sayadi Lohrasb R, Alhunayan Danah, Sarantopoulos Nikolaos, Kong Christina, Condamoor Shreya, Sayadi Jamasb, Banyard Derek A, Shaterian Ashkaun, Leis Amber, Evans Gregory R D, Widgerow Alan D
From the Department of Plastic Surgery, Center for Tissue Engineering, University of California, Irvine, Orange.
Stanford University School of Medicine, Stanford, CA.
Ann Plast Surg. 2019 Nov;83(5):594-600. doi: 10.1097/SAP.0000000000001918.
Ever since the classification of Dupuytren disease into the proliferative, involutional, and residual stages, extensive research has been performed to uncover the molecular underpinnings of the disease and develop better treatment modalities for patients. The aim of this article is to systematically review the basic science literature pertaining to Dupuytren disease and suggest a new approach to treatment.
Following Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, a systematic review was conducted using the MEDLINE database to identify basic science literature on Dupuytren pathophysiology falling under 1 or more of the following categories: (1) Molecular alterations, (2) Structural alterations, and (3) Genetic predisposition.
A total of 177 articles were reviewed of which 77 studies met inclusion criteria. Articles were categorized into respective sections outlined in the study methods.
The pathophysiological changes involved in Dupuytren's disease can be divided into a number of molecular and structural alterations with genetic predisposition playing a contributory role. Understanding these changes can allow for the development of biologics which may disrupt and halt the disease process.
自从将杜普伊特伦挛缩病分为增殖期、 involutional期和残留期以来,人们进行了广泛的研究,以揭示该疾病的分子基础,并为患者开发更好的治疗方法。本文的目的是系统地回顾与杜普伊特伦挛缩病相关的基础科学文献,并提出一种新的治疗方法。
按照系统评价和Meta分析的首选报告项目指南,使用MEDLINE数据库进行系统评价,以识别属于以下1个或多个类别的关于杜普伊特伦挛缩病病理生理学的基础科学文献:(1)分子改变,(2)结构改变,以及(3)遗传易感性。
共审查了177篇文章,其中77项研究符合纳入标准。文章被分类到研究方法中概述的各个部分。
杜普伊特伦挛缩病所涉及的病理生理变化可分为一些分子和结构改变,遗传易感性起一定作用。了解这些变化有助于开发可能干扰和阻止疾病进程的生物制剂。